# AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects

> **NCT00769899** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** AZD7325
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00769899
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2009-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769899, "AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00769899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*